The revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI) can be used to assess disease activity and damage. Acute cutaneous LE affects at least 50% of patients with systemic lupus erythematosus (SLE). Specific features of acute cutaneous LE may include: See more images of systemic lupus erythematosus. Plaquenil and itchy eyes How long to see effects of plaquenil Plaquenil back pain Chloroquine half life Cutaneous lupus erythematosus encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. Cutaneous lupus is divided into several subtypes, including acute cutaneous lupus erythematosus, subacute cutaneous lupus erythematosus, and chronic cutaneous lupus erythematosus. Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except. Aug 07, 2018 Subacute cutaneous lupus erythematosus SCLE is a nonscarring, non–atrophy-producing, photosensitive dermatosis. SCLE commonly develops in sun-exposed areas, including the upper back, shoulders, extensor arms, neck, and upper torso, while the face is often spared. One-third of the cases are due to previous drug exposure. About 15% of patients with cutaneous LE have subacute cutaneous LE. Plaquenil for cutaneous lupus Subacute Cutaneous Lupus Erythematosus SCLE - Dermatology., What Conditions does Plaquenil Treat? - WebMD Wikipedia hydroxychloroquineNot diagnosed with rd but on methotrexate and plaquenilCommon side effects of plaquenilChloroquine 250mgRecommended eye tests for sjogrens plaquenil Lupus and Plaquenil research. While Plaquenil was not created with the explicit purpose of helping people minimize the disease activity of lupus, a number of clinical trials have been conducted to examine the clinical impact of the medication. Plaquenil Hydroxychloroquine for Lupus - LupusCorner. Subacute Cutaneous Lupus Erythematosus SCLE Medication.. Treating Lupus with Anti-Malarial Drugs Johns Hopkins.. Chronic cutaneous lupus erythematosus. Chronic cutaneous LE accounts for 80% of presentations with cutaneous LE. About 25% of patients with chronic cutaneous LE also have systemic LE. Discoid LE. Discoid LE is the most common form of chronic cutaneous LE. It is more prevalent in patients with skin of colour, who are at greater risk of postinflammatory hyperpigmentation and hypertrophic scarring. Plaquenil is also an antirheumatic medicine and is used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. Important information. Taking Plaquenil long-term or at high doses may cause irreversible damage to the retina of your eye. Hydroxychloroquine is a one of a number of drugs which have been used for many years in the treatment of malaria. Fortunately, it was discovered these drugs often are helpful in the treatment of various rheumatic diseases, particularly systemic lupus erythematosus SLE or "Lupus" and rheumatoid arthritis.